Notice of Proposed Settlement of Class Action Involving Any Person Who or Which Purchased NowRx Stock from February 1, 2022 through July 1, 2022
NEW YORK, April 3, 2025 /PRNewswire/ -- The following statement is being issued by Squitieri & Fearon, LLP regarding the Seed Invest Technology Settlement: